246 related articles for article (PubMed ID: 8803913)
1. The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review.
Wallace DJ
Lupus; 1996 Jun; 5 Suppl 1():S59-64. PubMed ID: 8803913
[TBL] [Abstract][Full Text] [Related]
2. [Antimalarial drugs in contemporary dermatologic therapy].
Kiedrowicz M; Kacalak-Rzepka A; Bielecka-Grzela S; Maleszka R
Ann Acad Med Stetin; 2011; 57(1):38-44. PubMed ID: 22593989
[TBL] [Abstract][Full Text] [Related]
3. [Chloroquine--miscellaneous properties of the antimalarial drug].
Jarzyna R
Postepy Hig Med Dosw; 2002; 56(2):169-84. PubMed ID: 12107961
[TBL] [Abstract][Full Text] [Related]
4. [Synthetic antimalarials].
Fardet L; Revuz J
Ann Dermatol Venereol; 2005; 132(8-9 Pt 1):665-74. PubMed ID: 16230916
[TBL] [Abstract][Full Text] [Related]
5. Use of antimalarials in dermatology.
Ochsendorf FR
J Dtsch Dermatol Ges; 2010 Oct; 8(10):829-44; quiz 845. PubMed ID: 20678149
[TBL] [Abstract][Full Text] [Related]
6. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.
Kreuter A; Gaifullina R; Tigges C; Kirschke J; Altmeyer P; Gambichler T
Arch Dermatol; 2009 Mar; 145(3):244-8. PubMed ID: 19289751
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial agents and lupus.
Wallace DJ
Rheum Dis Clin North Am; 1994 Feb; 20(1):243-63. PubMed ID: 8153401
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of porphyria cutanea tarda with chloroquine and its effect on associated liver disease: retrospective analysis].
Wolff C; Armas R; Krause P; Parraguez A; Ramón Soto J
Rev Med Chil; 1996 Apr; 124(4):456-60. PubMed ID: 9110486
[TBL] [Abstract][Full Text] [Related]
9. [Current therapeutic methods in porphyria cutanea tarda].
Giannotti B
G Ital Dermatol Venereol; 1984; 119(3):167-9. PubMed ID: 6746011
[No Abstract] [Full Text] [Related]
10. Antimalarial treatment of rheumatoid arthritis: 1985 status.
Rynes RI
J Rheumatol; 1985 Aug; 12(4):657-9. PubMed ID: 4057186
[No Abstract] [Full Text] [Related]
11. Treatment of cutaneous sarcoidosis with chloroquine. Review of the literature.
Zic JA; Horowitz DH; Arzubiaga C; King LE
Arch Dermatol; 1991 Jul; 127(7):1034-40. PubMed ID: 2064404
[TBL] [Abstract][Full Text] [Related]
12. Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study.
Stölzel U; Schuppan D; Tillmann HL; Manns MP; Tannapfel A; Doss MO; Zimmer T; Köstler E
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):43-7. PubMed ID: 11929046
[TBL] [Abstract][Full Text] [Related]
13. Subacute cutaneous lupus erythematosus with bullae associated with porphyria cutanea tarda.
Peitsch WK; Lorentz K; Goebeler M; Goerdt S
J Dtsch Dermatol Ges; 2007 Mar; 5(3):220-2. PubMed ID: 17338797
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
Raff M; Formanek I
Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine treatment of porphyria cutanea tarda.
Malkinson FD; Levitt L
Arch Dermatol; 1980 Oct; 116(10):1147-50. PubMed ID: 7425660
[TBL] [Abstract][Full Text] [Related]
16. Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.
Plantone D; Koudriavtseva T
Clin Drug Investig; 2018 Aug; 38(8):653-671. PubMed ID: 29737455
[TBL] [Abstract][Full Text] [Related]
17. Porphyria cutanea tarda affecting lower lip.
Martínez A; Morales R; Brethauer U; Jiménez M; Alarcón R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):705-8. PubMed ID: 11113814
[TBL] [Abstract][Full Text] [Related]
18. Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action.
Katz SJ; Russell AS
Curr Opin Rheumatol; 2011 May; 23(3):278-81. PubMed ID: 21448012
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial therapy in SLE.
Lanham JG; Hughes GR
Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
[No Abstract] [Full Text] [Related]
20. The devil's in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda.
Sunkara B; Roofeh D; Silver S; Pearson TL; Ettel M; McCune WJ
Lupus; 2018 Jul; 27(8):1383-1386. PubMed ID: 29631513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
